InMed Pharmaceuticals Inc...

NASDAQ: INM · Real-Time Price · USD
2.24
-0.06 (-2.61%)
At close: Aug 19, 2025, 3:59 PM
2.25
0.45%
After-hours: Aug 19, 2025, 04:04 PM EDT

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals reported an annual revenue of $6.29M, reflecting a 14.77% growth. For the quarter ending March 31, 2025, InMed Pharmaceuticals generated $1.8M in revenue.
Revenue (ttm)
6.29M
Revenue Growth
14.77%
Price / Sales Ratio
0.61
Revenue / Employee
483.69K
Employees
13
Market Cap
4.48M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Jun 30, 2024 6.29M +14.77%
Jun 30, 2023 5.48M +290.57%
Jun 30, 2022 1.4M +Infinity%
Jun 30, 2021 0 n/a
Jun 30, 2020 0 n/a
Jun 30, 2019 0 n/a
Jun 30, 2018 0 n/a
Jun 30, 2017 0 n/a
Jun 30, 2016 0 n/a
Jun 30, 2015 0 n/a
Jun 30, 2014 0 n/a
Jun 30, 2013 0 n/a
Jun 30, 2012 0 -100.00%
Jun 30, 2011 39.66K -50.09%
Jun 30, 2010 79.46K -52.82%
Jun 30, 2009 168.42K -72.98%
Jun 30, 2008 623.37K -24.51%
Jun 30, 2007 825.79K -70.06%
Jun 30, 2006 2.76M -34.85%
Jun 30, 2005 4.23M +102.27%
Jul 31, 2004 2.09M +1027.38%
Jul 31, 2003 185.61K +1248.04%
Jul 31, 2002 13.77K +463.84%
Jul 31, 2001 2.44K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.